federal_register: E8-26793
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| E8-26793 | Notice of Approval of Original Abbreviated New Animal Drug Application; Phenylbutazone Tablets | Notice | The Food and Drug Administration (FDA) is providing notice that it has approved an original abbreviated new animal drug application (ANADA) filed by First Priority, Inc. The ANADA provides for veterinary prescription use of phenylbutazone tablets in horses for the relief of inflammatory conditions associated with the musculoskeletal system. | 2008-11-12 | 2008 | 11 | https://www.federalregister.gov/documents/2008/11/12/E8-26793/notice-of-approval-of-original-abbreviated-new-animal-drug-application-phenylbutazone-tablets | https://www.govinfo.gov/content/pkg/FR-2008-11-12/pdf/E8-26793.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is providing notice that it has approved an original abbreviated new animal drug application (ANADA) filed by First Priority, Inc. The ANADA provides for veterinary prescription use of phenylbutazone tablets in... |